These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 961429)

  • 1. Prolonged survival of AKR mice treated with the saponin adjuvant Quil A.
    Ebbesen P; Dalsgaard K; Madsen M
    Acta Pathol Microbiol Scand A; 1976 Jul; 84(4):358-60. PubMed ID: 961429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tissue specific mitotic inhibitors on survival time of spontaneous and virus-induced murine leukaemia and influence on myocardial degeneration.
    Ebbesen P; Olsson L
    Scand J Haematol; 1978 Aug; 21(2):131-8. PubMed ID: 694424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
    Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
    Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the adjuvants SGP and Quil A on the induction of experimental autoimmune thyroiditis in mice.
    Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H
    Cell Immunol; 1987 Feb; 104(2):296-303. PubMed ID: 3815534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations.
    Flebbe LM; Braley-Mullen H
    Cell Immunol; 1986 Apr; 99(1):128-39. PubMed ID: 3489558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens.
    Flebbe LM; Braley-Mullen H
    Cell Immunol; 1986 Apr; 99(1):119-27. PubMed ID: 3489557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant effect of Quil-A on the porcine humoral immune response (author's transl)].
    Houdayer M; Rouze P; Dalsgaard K; Metzger JJ
    Ann Immunol (Paris); 1978 Jan; 129(1):107-12. PubMed ID: 655643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic activity of pretazettine, a narcissus alkaloid, on spontaneous AKR leukemia.
    Furusawa E; Lockwood RH; Furusawa S; Lum MK; Lee JY
    Chemotherapy; 1979; 25(5):308-15. PubMed ID: 225136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the isolation and characterization of the saponin Quil A. Evaluation of its adjuvant activity, with a special reference to the application in the vaccination of cattle against foot-and-mouth disease.
    Dalsgaard
    Acta Vet Scand Suppl; 1978; (69):7-40. PubMed ID: 102135
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between white blood cell count and diagnosis and therapeutic response in AKR mice with spontaneous leukemia (lymphoma).
    Kende M; Goldberg AI; Glynn JP; Mantel N; Goldin A
    Cancer Chemother Rep; 1972 Dec; 56(6):683-90. PubMed ID: 4660628
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and evaluation of immunological adjuvant activities of saponins from the roots of Pulsatilla chinensis with less adverse reactions.
    Sun Y; Liu J; Yu H; Gong C
    Int Immunopharmacol; 2010 May; 10(5):584-90. PubMed ID: 20159051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bovine ephemeral fever vaccine incorporating adjuvant Quil A: a comparative study using adjuvants Quil A, aluminium hydroxide gel and dextran sulphate.
    Vanselow BA; Abetz I; Trenfield K
    Vet Rec; 1985 Jul; 117(2):37-43. PubMed ID: 2412334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluorometry of nuclear acridine orange metachromasia in lymphocytes of thymus, spleen, and blood of AKR and random-bred mice.
    Alvarez MR
    Cancer Res; 1976 Mar; 36(3):895-900. PubMed ID: 56232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunological adjuvant activities of saponin rich fraction from the fruits of
    Singh R; Sharma R; Varshney R; Mal G; Ghosh M; Singh B
    Drug Chem Toxicol; 2023 May; 46(3):557-565. PubMed ID: 35484852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in saponin-based adjuvants.
    Sun HX; Xie Y; Ye YP
    Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic and immunologic effects of iodoacetate in mature AKR mice.
    Rheins MS; Barker AD
    Experientia; 1973 Apr; 29(4):476-7. PubMed ID: 4575260
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of antitumor activities of pancreatic ribonuclease and its cross-linked dimer.
    Tarnowski GS; Kassel RL; Mountain IM; Blackburn P; Wilson G; Wang D
    Cancer Res; 1976 Nov; 36(11 Pt 1):4074-8. PubMed ID: 975050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.